AgelessRx has partnered with Longevity Labs on a descriptive study that has shown positive results for quality-of-life outcomes.
Learn about AgelessRx’s recent gift to the Michigan Medicine Division of Geriatric and Palliative Medicine Geriatrics Center.
Check out this video webinar series about a new AgelessRx sponsored study on the use of Rapamycin in longevity treatment.
AgelessRx is working to get more traction on clinical and scientific studies that can help us learn more about how LDN may impact longevity.
AgelessRx Co-Founder & Chief Medical Officer, Dr. Sajad Zalzala, updates on the growth of ARX and its big future plans at Healthcare Future.
AgelessRx has started recruiting participants to our clinical trial PEARL (Participatory Evaluation of Aging with Rapamycin for Longevity).
ARX CMO Dr. Zalzala introduces new post-COVID-19 pilot study and shares how LDN and NAD+ may help with post-COVID-19 Syndrome.
Anar Isman, Co-Founder & CEO of AgelessRx, recently sat down with Longevity.Technology to talk about ARX’s online platform and mission.
Chief Executive Officer, Anar Isman, recently sat down with Longevity Technology to talk about ARX’s noteworthy Rapamycin clinical trial.
AgelessRx CMO Dr. Zalzala sat down with Startup.Info to discuss all things longevity prescriptions that may help enhance your immune system.
Dr. Zalzala, AgelessRx Chief Medical Officer, sat down with Linda Elsegood of LDN Radio to discuss all things LDN. Check out the recording!